U.S. Online Retail and Ecommerce Stock News

SiteOne Landscape Supply reported its fourth-quarter 2025 results, with sales rising to US$1,045.6 million and its quarterly net loss narrowing to US$9 million, while full-year sales reached US$4,704.8 million and net income increased to US$151.8 million. The company also improved its earnings per share from continuing operations for the full year, with diluted EPS rising from US$2.71 to US$3.37, underlining higher profitability on slightly higher revenue. We’ll now examine how this...

Ichor Holdings (ICHR) just wrapped up FY 2025 with Q4 revenue of US$223.6 million and a basic EPS loss of US$0.46, while trailing twelve month figures show revenue of US$947.7 million and a basic EPS loss of US$1.54. Over recent quarters, the company has seen quarterly revenue move between US$211.1 million and US$244.5 million, with basic EPS losses ranging from US$0.08 to US$0.67. This pattern keeps the focus squarely on how efficiently each dollar of sales is translating into earnings. With...

McKesson (NYSE:MCK) has completed its exit from European operations to focus on North American businesses. The company plans a spin-off of its medical-surgical segment as part of a broader portfolio reshaping. Oncology and specialty businesses, along with technology solutions, reported strong performance in Q3. Management raised full-year guidance following Q3 results, reflecting the new business mix and priorities. For you as an investor, McKesson now appears more concentrated around its...

If you are wondering whether Insmed at around US$148.55 is still a sensible entry or hold after a strong run, the key question is how that price compares with its underlying value. The share price has seen a 5.5% decline over the last 7 days and a 15.6% decline over the last 30 days, even though the 1 year return is 85.9% and the 3 year return is very large. Recent attention on Insmed has centered on its position in the pharmaceuticals and biotech space and how the market is weighing its...

MSCI Inc. recently reported fourth-quarter 2025 results showing sales of US$822.53 million and net income of US$284.67 million, alongside announcing a first-quarter 2026 dividend of US$2.05 per share and the completion of multi-billion-dollar share repurchase programs. At the UBS Financial Services Conference and through its latest index review, MSCI underscored its push into AI-enabled tools and high-profile index inclusions, reinforcing its role as a key infrastructure provider to global...

BETA Technologies (BETA) has drawn fresh attention after recent trading left the stock with a 1 day return of 0.30%, alongside negative moves over the past week, month, and past 3 months. See our latest analysis for BETA Technologies. The 0.30% 1 day share price return comes against a much weaker backdrop, with 7 day, 30 day, 90 day and year to date share price returns all firmly negative. This suggests recent momentum has been fading despite BETA Technologies trading at $16.77. If this shift...

Capgemini and Microsoft announced an expanded partnership to deliver end to end sovereign cloud and AI solutions, targeting clients with strict data residency and compliance needs. Microsoft shared new adoption metrics for its Copilot AI platform and highlighted fresh integrations with partners including TeamDynamix, Dragos, and CAEVES. The company is also investing in data center innovation, including exploring superconducting power lines to improve energy efficiency for AI workloads. For...

Ciena Corporation ( NYSE:CIEN ) shares have continued their recent momentum with a 30% gain in the last month alone...

Verizon Communications Inc. ( NYSE:VZ ) will increase its dividend from last year's comparable payment on the 1st of...

The loanDepot, Inc. ( NYSE:LDI ) share price has fared very poorly over the last month, falling by a substantial 27...

Molina Healthcare, Inc. ( NYSE:MOH ) shares have had a horrible month, losing 31% after a relatively good period...

V.F Corporation (NYSE:VFC) has announced senior leadership changes, including appointing Brent Hyder as Chief Commercial Officer. Martino Scabbia Guerrini will move from his current role into a senior advisory position to support the leadership transition. These changes reflect an internal reshuffle of executive responsibilities affecting how the company manages its global brands and commercial operations. For investors watching V.F at a share price of $20.91, these leadership shifts come...

iRhythm Technologies, Inc. has voluntarily deregistered its Common Stock. The company has completed a holding company reorganization. iRhythm Holdings, Inc. now serves as the new public entity for shareholders. The changes affect the stock associated with NasdaqGS:IRTC and the prior operating company. iRhythm focuses on cardiac monitoring solutions, so any change in its corporate structure tends to attract attention from investors who follow medical technology names. The move to a holding...

Amgen Inc.'s ( NASDAQ:AMGN ) dividend will be increasing from last year's payment of the same period to $2.52 on 6th of...

If you are wondering whether Tesla's current share price lines up with its underlying value, you are not alone. This article walks through what the numbers are actually saying. Tesla closed at US$425.21, with returns of 0.8% over the last week, a 4.4% decline over the last month, a 2.9% decline year to date, and a 29.4% gain over the past year, while the 3 year return is 103.2% and the 5 year return is 60.2%. Recent headlines around Tesla have focused on the broader electric vehicle sector,...

Incyte's drug Zynyz received a positive opinion from the European Medicines Agency's CHMP for use with chemotherapy as a first line treatment for metastatic or inoperable squamous cell carcinoma of the anal canal. The recommendation supports potential use of Zynyz in adult patients across the European Union, subject to final regulatory approval. For investors watching NasdaqGS:INCY, this regulatory progress comes with the stock trading at $100.05 and a 1 year return of 50.8%. Over 3 and 5...

Recent figures for Vita Coco Company (COCO) have caught investor attention, with unit sales rising 10.8% over the past two years and earnings per share growing 89.3% annually over the last three years. See our latest analysis for Vita Coco Company. Despite strong fundamentals, the recent 1 day share price return of a 3.17% decline and 1 week share price return of a 1.74% decline contrast with a 90 day share price return of 31.11% and a 1 year total shareholder return of 43.48%. This suggests...

Darden Restaurants (DRI) is closing its remaining 28 Bahama Breeze locations, with 14 set to shut permanently and 14 to be converted to other company brands, sharpening attention on its portfolio choices. See our latest analysis for Darden Restaurants. The Bahama Breeze exits come after a 19.68% 90 day share price return and a 12.30% year to date share price return. The 1 year total shareholder return of 11.53% and 5 year total shareholder return of 91.78% point to momentum that has been...

Why Airbnb is back on investors’ radar Airbnb (ABNB) has drawn fresh attention after a recent pullback, with the share price showing declines over the past month and year that contrast with the company’s latest reported revenue and net income figures. See our latest analysis for Airbnb. Airbnb’s recent 30 day share price return of a 13.6% decline and 1 year total shareholder return of a 10.6% loss suggest momentum has cooled, reflecting a more cautious stance on future growth and risk than in...

Alkermes (NasdaqGS:ALKS) received Irish High Court approval to acquire Avadel Pharmaceuticals. The court sanction means only formal delivery of the court order remains before the transaction can close. This approval is a key milestone in Alkermes' plan to expand its presence in the pharmaceutical market. For you as an investor, this court decision is a concrete step in Alkermes' effort to grow its drug portfolio and pipeline. Alkermes focuses on medicines for serious mental health and...

If you are wondering whether Coupang's current share price reflects its true value, you are not alone. This article focuses squarely on that question. The stock last closed at US$18.25, with returns of a 5.7% decline over 7 days, a 19.7% decline over 30 days, a 21.9% decline year to date and a 23.4% decline over 1 year, while the 3 year return sits at 17.4%. Recent headlines around Coupang have focused on its position as a major South Korean e-commerce platform listed in the US and how its...

CVS Health (CVS) closed out FY 2025 with fourth quarter revenue of US$105.1 billion, Basic EPS of US$2.32 and net income of US$2,943 million, following a year in which trailing twelve month revenue reached US$399.8 billion, Basic EPS stood at US$1.40 and net income was US$1,768 million. The company has seen quarterly revenue move from US$96.9 billion in Q4 2024 to US$105.1 billion in Q4 2025, while Basic EPS shifted from US$1.31 to US$2.32 over the same period, against a backdrop of a...

If you are wondering whether Synopsys at around US$437.45 is giving you fair value for the risk you are taking, you are asking the right question and this article is going to stay focused on exactly that. The stock has recently been mixed, with a 4.4% gain over the last 7 days, a 16.7% decline over 30 days, and year to date and 1 year returns of 8.9% and 17.3% declines respectively, set against longer term 3 year and 5 year returns of 16.4% and 50.5%. These moves are coming in the context of...

Teledyne Technologies recently began producing advanced infrared Focal Plane Modules for the Space Development Agency’s Tracking Layer Tranche 3 satellites, while also highlighting Teledyne FLIR OEM’s high-volume, vertically integrated thermal imaging operations serving defense, industrial, automotive, and uncrewed systems markets. The combination of space-focused infrared contracts and Teledyne FLIR OEM’s position as a large-scale, ITAR-free infrared foundry underscores Teledyne’s...